Skip to content

Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.

K K Szumlinski, I M Maisonneuve, S D Glick

European journal of pharmacology June 16, 2000 DOI: 10.1016/s0014-2999(00)00325-3 via PubMed

Summary

AI-generated from the abstract

Ibogaine, given to rats 19 hours before a cocaine challenge, reversed a key brain change caused by repeated cocaine use: the sensitized dopamine response in the nucleus accumbens. While ibogaine did not alter the dopamine increase from a single cocaine dose, it eliminated the amplified dopamine release that normally occurs in cocaine-sensitized animals. This effect on neuroadaptation may underlie ibogaine's proposed anti-addictive properties.

Study at a glance

Characteristics Experimental study Peer reviewed
Population Rats
Interventions Ibogaine Cocaine
Dose 40 mg/kg i.p. ibogaine; 20 mg/kg cocaine challenge; 5 x 15 mg/kg cocaine for sensitization
Topics Ibogaine
Keywords Addiction treatment Cocaine addiction Neuroadaptation
Citations 19
Key finding Ibogaine pretreatment reversed the expression of cocaine-induced dopamine sensitization in the nucleus accumbens without affecting the dopamine response to acute cocaine.

Abstract

To investigate a possible basis for the proposed anti-addictive property of ibogaine, the effects of ibogaine (40 mg/kg, i.p., 19 h earlier) on the expression of sensitization induced by cocaine were investigated. Ibogaine pretreatment potentiated the increase in the stereotypic effects of a cocaine challenge (20 mg/kg) in both sensitized (5 x 15 mg/kg, i.p.) and acutely treated rats. However, while ibogaine pretreatment did not significantly alter the dopamine response in the nucleus accumbens to acute cocaine, it abolished the expression of cocaine-induced dopamine sensitization. This result demonstrates that ibogaine pretreatment can reverse one of the neuroadaptations produced by chronic cocaine administration, an effect that may contribute to its putative anti-addictive property.

Explore topics

Comments

No comments yet.

Log in to comment